Hanish Singh, MD
Pain Medicine · East Lansing, MINPI 1962736785
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.1%. 2025 is the largest year on record at $4,384, 5.2 times the $843 reported in 2019.
Across 138 payments — averaging $76.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Nevro Corp.$1K
- Globus Medical$1K
- Curonix LLC$1K
- Abbott$1K
- Medtronic$913
- plus $2K from 17 others
What the payments were for
- Travel & lodging$4,51343%
- Food & beverage$6,00757%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 20 | $2,330 |
| Nevro Corp. | 28 | $1,446 |
| Globus Medical | 15 | $1,231 |
| Curonix LLC | 7 | $1,192 |
| Abbott | 13 | $1,045 |
| Medtronic(2 entities) | 12 | $913 |
| Nalu Medical, Inc. | 9 | $801 |
| Bioventus LLC | 5 | $726 |
| AbbVie(2 entities) | 9 | $284 |
| SPR Therapeutics, Inc | 2 | $185 |
| Dynasplint Systems Inc. | 1 | $69 |
| Amgen | 2 | $46 |
| Stryker | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Biodelivery Sciences International, Inc. | 2 | $32 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Lundbeck LLC | 1 | $29 |
| Si-bone, Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Virtus Pharmaceuticals LLC | 1 | $15 |
| Relievant Medsystems, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$1,411
- Senza$1,157
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$964
- Nalu Neurostimulation System$745
- Stimrouter Implantable Kit$660
- RESTORE$558
- Proclaim Family of SCS IPGs$441
- Senza Spinal Cord Stimulation System$392
- WaveWriter Alpha Prime 16$334
- PROCLAIM$304
- Omnia$292
- UBRELVY$125
- SPRINT PNS System$107
- GENERAL PAIN MANAGEMENT$105
- SUPERION$100
How this compares
$10,542 in reported general payments places this provider in the 80th percentile of 139 pain medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PercocetOxycodone Hcl/Acetaminophen | 11 | $24,738 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 259 | $3,732 |
| Lidocaine | 41 | $3,464 |
| Buprenorphine | 11 | $2,693 |
| Pregabalin | 167 | $2,555 |
| Gabapentin | 235 | $2,478 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 108 | $2,128 |
| Diclofenac Sodium | 25 | $1,706 |
| Morphine Sulfate ErMorphine Sulfate | 26 | $638 |
| Tramadol Hcl | 113 | $527 |
| Methocarbamol | 31 | $448 |
| Celecoxib | 18 | $448 |
| Morphine Sulfate | 18 | $341 |
| Methylprednisolone | 56 | $289 |
| Cyclobenzaprine Hcl | 35 | $288 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $21 | $3,03429 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 139 pain medicine providers in Michigan.
Other pain medicine in East Lansing
- Harry SukumaranRochester Hills$304K
- Nasir KhatriFlint$133K
- Yijia ChuGrand Rapids$88K
- Mark MounayerSouthfield$85K
- Jeffrey RosenbergCanton$44K
- Alexander TurfeWyandotte$41K
- Kendall GroseWyandotte$26K
- Craig HartrickRoyal Oak$26K
- Patrick ForrestAnn Arbor$23K
- Anmar DalatiDetroit$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.